Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing
Ryley Uber
The Geisinger MyCode® Community Health Initiative has been underway for nearly 2 decades, positively influencing our understanding of how genomics affect health while enabling pathways for clinical confirmation of genomic results. Yet a key question remains:
How can MyCode pharmacogenomic (PGx) data be used to improve medication outcomes